Generation of human induced pluripotent stem cell lines from three different male XLRS patients carrying RS1 gene mutation
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Researchers created induced pluripotent stem cells (iPSCs) from patients with X-linked retinoschisis (XLRS). These patient-derived iPSC lines are crucial for studying XLRS disease and developing new treatments.
Area Of Science
- Ophthalmology
- Genetics
- Stem Cell Biology
Background
- X-linked retinoschisis (XLRS) is a genetic retinal disease.
- RS1 gene mutations cause XLRS.
- Limited cell sources hinder XLRS research and therapeutic development.
Purpose Of The Study
- To generate patient-derived induced pluripotent stem cell (iPSC) lines for X-linked retinoschisis (XLRS) research.
- To establish valuable cellular models for studying XLRS pathogenesis.
- To facilitate the advancement of therapeutic strategies for XLRS.
Main Methods
- Generated iPSC lines from three XLRS patients with distinct RS1 pathogenic variants.
- Characterized iPSC lines for pluripotency and in vitro differentiation potential.
- Assessed iPSC lines for normal karyotype.
Main Results
- Successfully generated iPSC lines from XLRS patients.
- Confirmed pluripotency and differentiation capacity of the generated iPSC lines.
- Verified normal karyotype in all established iPSC lines.
Conclusions
- Patient-derived iPSC lines are a valuable resource for XLRS research.
- These iPSC lines can be used to model XLRS pathogenesis.
- The established iPSC lines support the development of novel therapeutic interventions for XLRS.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
iPSCs have been successfully used to treat age-related macular degeneration (AMD), a form of...